Latest Articles
- Aspirin for primary prevention of cardiovascular disease: What do the current USPSTF guidelines say?
A concise overview of the US Preventive Services Task Force recommendations.
- Cholesteatoma
The patient’s audiogram showed left-sided conductive hearing loss, and examination revealed an atelectatic tympanic membrane on the left with a retraction pocket and keratin debris.
Endocrinopathies from checkpoint inhibitors: Incidence, outcomes, and managementA review of the incidence and severity of each immune checkpoint inhibitor-related endocrinopathy, factors related to toxicity risk, and principles of management.
- Aspirin in primary prevention of cardiovascular events: Key questions remain
Are we done with the issue of aspirin in primary prevention? Not quite yet.
- What is the optimal approach to infiltration and extravasation of nonchemotherapy medications?
The immediate response is warm or cold compression and assessment of the severity.
- Reincarnating autoimmunity: Immune-related adverse events as new diseases
The range of adverse events is broad. Any organ can be affected, and any naturally occurring autoimmune process can be mimicked by the massive inflammation generated by checkpoint inhibition.
- Chronic centralized pain syndromes: A rheumatologist’s perspective
Centralized pain syndromes are vexing for patients and clinicians. In this issue, Volcheck and colleagues present a framework for understanding chronic centralized pain and for developing an actionable treatment plan for patients.
- Diagnosis and management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome
A review of recommendations from the American Association for the Study of Liver Diseases.
- Central sensitization, chronic pain, and other symptoms: Better understanding, better management
Clinicians have a pivotal role by providing patient education, which can affect perception, management, functional status, and quality of life.